# RNN 1st Gen Model Monsanto Company Agricultural chemicals

Stock predictor AI models:
76.19% successful of 63 deals
$ 9.78 Last close price
at 18-oct-2021


Model's trade recommendations 1.72% Return for period

5.60% Annual return

$55.19B Market Cap

β 0.95  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 1.72%
52wk return 5.21%
52wk Range
Sortino ratio 0.72
Sharpe ratio 0.52
Norm. RMSE 0.63%
Downside risk 7.97%
Volatility 0.00%
  • 2.16 (1.73%) Div (Yield)
  • HOLD Analysts consensus recommendation

Monsanto Company is a leading global provider of agricultural products for farmers. Monsanto develop products and tools to help farmers around the world grow crops while using energy, water, and land more efficiently. Monsanto believe innovation has the potential to bring humanity's needs in balance with the resources of planet. Monsanto seeds, biotechnology trait products, herbicides and digital agriculture products provide farmers with solutions that help improve productivity, reduce the costs of farming and produce better foods for consumers and better feed for animals. Monsanto manage business in two reportable segments: Seeds and Genomics and Agricultural Productivity. Monsanto Seeds and Genomics segment as the driver for future growth for company. In Agricultural Productivity segment, global glyphosate producers have substantial capacity to supply the market, and expect this global capacity to maintain pressure on margins.

Industry sector: Basic Materials

Sector classification: Agricultural chemicals

Deep Learning based analysis and prediction model for Monsanto Company (MON) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for MON model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for MON.

Model is being retrained on a daily basis.

Float 437M
P/E 21.74
Shares Outstanding 441M
% Held by Insiders 0.79%
% Held by Institutions 76.10%
EPS (last reported FY) $5.50
EPS (last reported Q) $3.22
EPS, estimated (last reported Q) $3.38
Total revenues $15 B
Net income $2 B